The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Economic analysis of the confronting COPD survey: an overview of results
Open accessAbstract
An economic analysis of data from a large-scale international survey, Confronting COPD in North America and Europe, was conducted in seven countries (Canada, France, Italy, The Netherlands, Spain, the U.K and the U.SA.), to investigate the burden of chronic obstructive pulmonary disease (COPD). The results demonstrated the high economic impact of COPD on the healthcare system and society in each country. The mean annual direct costs of the disease were particularly high in the U.S.A. (US dollar 4119 per patient) and Spain (US dollar 3196 per patient) but relatively low in The Netherlands (US dollar 606) and France (US dollar 522). Lost productivity due to COPD had a particularly high impact on the economy in France, The Netherlands and the U.K, accounting for 67%, 50% and 41% of overall costs, respectively. The total societal cost of COPD per patient ranged from over US dollar 5646 in the U.S.A. to US dollar 1023 in The Netherlands. In five out of seven countries, the majority (52-84%) of direct costs associated with COPD were due to inpatient hospitalizations. As acute exacerbations of COPD are a key driver of secondary care costs, interventions aimed at preventing and treating exacerbations effectively could significantly reduce the economic impact of this disease. In all of the participating counties, COPD was underdiagnosed and undertreated. Between 9% and 30% of patients were undiagnosed despite having symptoms consistent with COPD, and up to 65% of patients did not receive regular prescribed medication. Patients reported poor symptom control and considerable use of healthcare resources. Therefore, reducing the burden of COPD will involve better evaluation and diagnosis of patients with COPD, as well as improved management of chronic COPD symptoms by healthcare professionals. The survey also demonstrated that the societal costs of COPD were 4-17 times higher in patients with severe COPD than in patients with mild COPD. Patients with comorbid conditions (accounting for 30-57% of patients in each country) were also particularly costly to society. These results suggest that a high priority should be given to interventions aimed at delaying the progression of disease, preventing exacerbations and reducing the risk of comorbidities, in order to alleviate the clinical and economic burden of COPD in North America and Europe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Guidelines for the management of chronic obstructive pulmonary disease
Buist, A. S. (2002) · Respiratory Medicine · doi:10.1016/s0954-6111(02)80029-4 · Cited by 607
Rennard, S., Decramer, M., Calverley, P. M. A., Pride, N. B., Soriano, J. B., Vermeire, P. A., & Vestbo, J. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.03242002 · Cited by 563
Pauwels, R., Buist, A. S., Calverley, P. M., Jenkins, C. R., & Hurd, S. S. (2001) · Cited by 409
Patterns of Absolute Risk of Lung Cancer Mortality in Former Smokers
Halpern, M. T., Gillespie, B. W., & Warner, K. E. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.6.457 · Cited by 319
Recent trends in physician diagnosed COPD in women and men in the UK
Soriano, J. B. (2000) · Thorax · doi:10.1136/thorax.55.9.789 · Cited by 307
The Costs of Treating COPD in the United States
Strassels, S. A., Smith, D. H., Sullivan, S. D., & Mahajan, P. S. (2001) · Chest · doi:10.1378/chest.119.2.344 · Cited by 287
Mapel, D. W., Hurley, J. S., Frost, F. J., Petersen, H. V., Picchi, M. A., & Coultas, D. B. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.17.2653 · Cited by 252
Cited by
López‐Campos, J. L., Tan, W., & Soriano, J. B. (2016) · Respirology · doi:10.1111/resp.12660 · Cited by 927
Underreporting Exacerbation of Chronic Obstructive Pulmonary Disease in a Longitudinal Cohort
Langsetmo, L., Platt, R. W., Ernst, P., & Bourbeau, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1290oc · Cited by 319
Kardos, P., Wencker, M., Glaab, T., & Vogelmeier, C. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-244oc · Cited by 314
Prevention of Acute Exacerbations of COPD
Criner, G. J., Bourbeau, J., Diekemper, R. L., Ouellette, D. R., Goodridge, D., Hernandez, P., Curren, K., Balter, M. S., Bhutani, M., Camp, P. G., et al. (2015) · Chest · doi:10.1378/chest.14-1676 · Cited by 288
Cost-of-Illness Studies: A Review of Current Methods
Akobundu, E., Ju, J., Blatt, L., & Mullins, C. D. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624090-00005 · Cited by 279
Metadata
- Authors
- Wouters, E. F. M.
- Venue
- Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 97
- Pages
- S3-S14
- ISSN
- 0954-6111 (ISSN-L)
- OpenAlex
- W2006386585
- Cited by
- 254
- References
- 19
- FWCI
- 13.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Economic analysis of the confronting COPD survey: an overview of results. https://app.cochat.ai/papers/10.1016/s0954-6111(03)80020-3
- The paper
- Wouters, E. F. M. (2003). Economic analysis of the confronting COPD survey: an overview of results. Respiratory Medicine. https://doi.org/10.1016/s0954-6111(03)80020-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.